Pfizer to cease vaccine sales business in China

Pfizer is ceasing vaccine sales operations in China after the Chinese government fails to renew an import license for one of its products, a move that the company says will cause a shortage of the treatment in China.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.